{"id":6587,"date":"2026-04-23T10:24:04","date_gmt":"2026-04-23T10:24:04","guid":{"rendered":"https:\/\/dev.fisvi.com\/blog\/fis-and-sq-innovation\/"},"modified":"2026-05-19T09:51:43","modified_gmt":"2026-05-19T09:51:43","slug":"fis-and-sq-innovation","status":"publish","type":"post","link":"https:\/\/dev.fisvi.com\/it\/blog\/fis-and-sq-innovation\/","title":{"rendered":"FIS and SQ Innovation"},"content":{"rendered":"\n<p>Through this partnership, FIS will ensure the long-term availability of high-quality, pharmaceutical-grade furosemide active pharmaceutical ingredient (API), supporting SQ Innovation\u2019s current products and future pipeline in the United States, Europe, and other global markets.<\/p>\n\n<p>As a leading Italian manufacturer and one of Europe\u2019s foremost API producers, we will be a key supply partner.<br\/>As our CEO, Daniele Piergentili, highlighted: \u201cBy combining our advanced manufacturing expertise with rigorous quality and regulatory standards, we can provide a strong, reliable supply foundation for this proven ingredient for innovative products, to the benefit of patients worldwide\u201d.<\/p>\n\n<p>To learn more, <a href=\"https:\/\/www.prnewswire.com\/news-releases\/sq-innovation-and-fis-announce-strategic-supply-agreement-for-furosemide-api-302743074.html\" data-type=\"link\" data-id=\"https:\/\/www.prnewswire.com\/news-releases\/sq-innovation-and-fis-announce-strategic-supply-agreement-for-furosemide-api-302743074.html\">click here<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Through this partnership, FIS will ensure the long-term availability of high-quality, pharmaceutical-grade furosemide active pharmaceutical ingredient (API), supporting SQ Innovation\u2019s current products and future pipeline in the United States, Europe, and other global markets. As a leading Italian manufacturer and one of Europe\u2019s foremost API producers, we will be a key supply partner.As our CEO, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":5859,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_seopress_robots_primary_cat":"19","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","footnotes":""},"categories":[20],"tags":[],"class_list":["post-6587","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-senza-categoria"],"acf":[],"_links":{"self":[{"href":"https:\/\/dev.fisvi.com\/it\/wp-json\/wp\/v2\/posts\/6587","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dev.fisvi.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dev.fisvi.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dev.fisvi.com\/it\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dev.fisvi.com\/it\/wp-json\/wp\/v2\/comments?post=6587"}],"version-history":[{"count":1,"href":"https:\/\/dev.fisvi.com\/it\/wp-json\/wp\/v2\/posts\/6587\/revisions"}],"predecessor-version":[{"id":6588,"href":"https:\/\/dev.fisvi.com\/it\/wp-json\/wp\/v2\/posts\/6587\/revisions\/6588"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dev.fisvi.com\/it\/wp-json\/wp\/v2\/media\/5859"}],"wp:attachment":[{"href":"https:\/\/dev.fisvi.com\/it\/wp-json\/wp\/v2\/media?parent=6587"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dev.fisvi.com\/it\/wp-json\/wp\/v2\/categories?post=6587"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dev.fisvi.com\/it\/wp-json\/wp\/v2\/tags?post=6587"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}